Navigation Links
EMBL reaches north
Date:10/3/2007

Today the European Molecular Biology Laboratory (EMBL), the University of Helsinki, Finland, the University of Oslo, Norway, and Ume University, Sweden, officially launch their new Nordic EMBL Partnership for Molecular Medicine. The agreement will encourage scientific exchange and collaborations between the partners and will facilitate access to respective scientific infrastructure, facilities and services for an initial period of five years.

The partnership between EMBL, the Institute for Molecular Medicine Finland, the Centre for Molecular Medicine Norway and the Laboratory for Molecular Infection Medicine Sweden is dedicated to molecular medicine, a growing field in the life sciences that investigates the molecular basis of disease and explores molecularly and genetically based treatments.

Each partner has a long history of research in specific areas relevant to molecular medicine and brings in a unique set of expertise, skills and facilities, says Iain Mattaj, Chair of the partnerships steering committee and Director General at EMBL. Combining complementary strengths in the new Nordic EMBL Partnership equips us to tackle some of the most challenging problems of biomedicine.

EMBLs recognised research strengths in the areas of molecular, cellular and developmental biology, bioinformatics and structural biology will be complemented by Norways expertise in molecular mechanisms of disease, Swedens focus on microbial pathogenicity and molecular infection medicine and Finlands strength in genetic epidemiology.

The agreement will facilitate access to scientific infrastructure, including databases, facilities and instrumentation, as well as to services and training activities provided by the partners. The partnership will result in the adoption of the EMBL model for international recruitment, staff turnover and scientific reviews to the Nordic nodes. The coordination between the Nordic nodes and EMBL will be overseen by a steeri
'/>"/>

Contact: Anna-Lynn Wegener
wegener@embl.de
49-622-138-7452
European Molecular Biology Laboratory
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. SARS reaches Russian Federation
2. Birds Flu Scare Reaches Germany
3. Number Of Bird Flu Cases In Switzerland Reaches 11
4. Cholera Death Toll Reaches 1,156 in Angola
5. Indonesia’s Bird Flu Death Toll Reaches 3
6. Indonesias Bird Flu Death Toll Reaches 42
7. Dengue Cases in West Bengal Reaches 400 Mark
8. Chikungunya Reaches Sri Lanka
9. Rise In Obesity Among North Qeenslanders
10. Northfield Labs Receives FDA Comments
11. Brain Fever or Encephalitis Spreading in North India
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 2Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 3Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 4Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 5Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 6Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 7Reportlinker Adds Radiation Therapy Equipment - A Global Market Review 8Reportlinker Adds Training Manikins - Global Trends 2Reportlinker Adds Training Manikins - Global Trends 3Reportlinker Adds Training Manikins - Global Trends 4Reportlinker Adds Training Manikins - Global Trends 5Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 2Particle Sciences and IES Engineers Cooperate on High Potency Compound Handling Capabilities 3Global health funding soars boosted by unprecedented private giving 49438 1Global health funding soars boosted by unprecedented private giving 49438 2Global health funding soars boosted by unprecedented private giving 49438 3KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 1KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 2KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 3KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 4KV Pharmaceutical Forms Licensing Partnership with Gedeon Richter 49436 5Traumatic brain injury caused by exposure to explosive blast presents critical challenge 49434 1Traumatic brain injury caused by exposure to explosive blast presents critical challenge 49434 2